CMH.ST Stock Analysis
CM
Uncovered
Chordate Medical Holding publ AB is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
13/100
Low score
Chordate Medical Holding AB engages in the development of product system for a nerve-stimulating treatment. The company is headquartered in Kista, Stockholm. The company went IPO on 2017-03-08. The firm develops treatment method through nerve stimulation for chronic nasal congestion. The Company’s headquartered is located in Kista, Sweden.
View Section: Eyestock Rating